Abstract:Abstract Background: Phosphoglycerate mutase 5 (PGAM5) regulates mitochondrial dynamics and programmed cell death, which relates to the pathogenesis of Parkinson’s disease (PD). This study aimed to examine whether plasma PGAM5 was a biomarker for PD diagnosis, and whether which was associated with the severity of motor or nonmotor manifestations of PD.Methods: Our data enrolled 124 patients of PD (PD group) and 50 healthy controls (HC group) , baseline characteristics of both groups were collected. We measured plasma PGAM5 levels with a quantitative sandwich enzyme immunoassay technique (ELISA). PD group received evaluations at baseline with the Unified Parkinson’s Disease Rating Scale (UPDRS); Mini-Mental State Examination (MMSE) score, Hamilton depression Rating Scale (HAMD), Hamilton Anxiety Rating Scale (HAMA), the Rating Scale of RBDQ-HK and Activity of Daily Living Scale (ADL) were finished both PD group and HC group. Receiver operator characteristic (ROC) curves were used to evaluate the predictive value of plasma PAMG5 alone and PAMG5 combined with other factors for PD diagnosis.Results: We found plasma PGAM5 levels were significantly higher in the patients with PD than HC groups, with an area under the curve (AUC) of 0.76. In terms of the subgroup analysis, the AUC for the elder subjects (＞60 years old) was 0.78, and for patients without hypertension was 0.79. Of note, when combined with plasma oligomeric α-synuclein (α-syn), AUC was 0.80; while combined with the score of the RBDQ-HK with an AUC of 0.82. Plasma PAMG5 levels were connected to PD independently in a multivariable logistic analysis (odds ratio,1.875 [95% CI 1.206-2.916], p=0.005), but showed no correlation with the severity of motor and other nonmotor manifestations of PD. Conclusions: Plasma PGAM5 was an independent biomarker for PD, aiding to distinguish PD from healthy controls, especially among those elder (＞60 years old) and patients without hypertension. The predictive value of PGAM5 would be elevated when combined with plasma oligomeric α-syn or the Rating Scale of RBDQ-HK.

Expression of the Gene Coading for PGC-1α in Peripheral Blood Leukocytes and Related Gene Variants in Patients with Parkinson's Disease

Cytokine Gene Polymorphisms and Parkinson's Disease: a Meta-Analysis.

Hypermethylation of the Gene Coding for PGC-1α in Peripheral Blood Leukocytes of Patients with Parkinson’s Disease

Association of Mitochondrial DNA Polymerase Γ Gene POLG1 Polymorphisms with Parkinsonism in Chinese Populations.

Association of Rare PPARGC1A Variants with Parkinson’s Disease Risk

PGC−1α Promoter Methylation in Parkinson’s Disease

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

Study of GCH1 and TH genes in Chinese patients with Parkinson's disease.

Plasma derived phosphoglycerate mutase 5 (PGAM5) as a biomarker for Parkinson’s disease

The Association Analysis of GPNMB Rs156429 with Clinical Manifestations in Chinese Population with Parkinson's Disease

PGC-1s in the Spotlight with Parkinson’s Disease

Analysis of the genotype of diacylglycerol kinase delta single-nucleotide polymorphisms in Parkinson disease in the Han Chinese population.

No Association of GPNMB Rs156429 Polymorphism with Parkinson’s Disease, Amyotrophic Lateral Sclerosis and Multiple System Atrophy in Chinese Population

Relation of PGC-1α Rs3774923 Polymorphism and Coronary Artery Disease in a Chinese Han Population

Genetic Variants in GAPDH Confer Susceptibility to Sporadic Parkinson’s Disease in a Chinese Han Population

ALDH1A1 Genetic Variations May Modulate Risk of Parkinson’s Disease in Han Chinese Population

Relationship Between Peroxisome Proliferator Activated Receptor Γ Coactivator-1Α Gly482Ser Variant and Glucose and Lipid Metabolism in Chinese Subjects and Patients

Plasma-derived Phosphoglycerate Mutase 5 As a Biomarker for Parkinson’s Disease

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases

Overexpression of PGC-1α Influences the Mitochondrial Unfolded Protein Response (mtupr) Induced by MPP+ in Human SH-SY5Y Neuroblastoma Cells

Mitochondrial Effects of PGC-1alpha Silencing in MPP+ Treated Human SH-SY5Y Neuroblastoma Cells